-

Alwyn van Heerden Joins MultiPlan as Vice President of Strategy and Corporate Development

Accomplished merger and acquisition strategist joins Finance team

NEW YORK--(BUSINESS WIRE)--MultiPlan Corporation (NYSE:MPLN) (“MultiPlan” or the “Company”), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, and payment and revenue integrity solutions to the U.S. healthcare industry, today announced Alwyn van Heerden joined MultiPlan as Vice President of Strategy and Corporate Development, effective November 14, 2022.

Mr. van Heerden will play a critical role in shaping and defining MultiPlan’s merger and acquisition (M&A) and partnership strategies. “With more than 14 years’ experience successfully originating and closing acquisitions and partnerships and structuring financings, Al is well qualified for this position,” said James Head, Chief Financial Officer for MultiPlan. “His record of accomplishment in strategy and M&A will be a valuable asset to our company.”

Most recently, Mr. van Heerden served as Senior Director, Corporate Development at Elevance Health (formerly Anthem, Inc.) where he led strategic acquisitions, investments, joint ventures, and other strategic relationships. He previously held positions at Rothschild & Co, Credit Suisse and Barclays Capital. Mr. van Heerden holds an MBA from the University of Rochester’s Simon Business School and is a CFA Charterholder.

About MultiPlan

MultiPlan is committed to helping healthcare payors manage the cost of care, improve their competitiveness and inspire positive change. Leveraging sophisticated technology, data analytics and a team rich with industry experience, MultiPlan interprets clients' needs and customizes innovative solutions that combine its payment integrity, network-based and analytics-based services. MultiPlan is a trusted partner to over 700 healthcare payors in the commercial health, government, property and casualty and dental markets. For more information, visit www.multiplan.com.

Contacts

Investor Relations
Luke Montgomery, CFA
SVP, Finance & Investor Relations
MultiPlan
866-909-7427
investor@multiplan.com

Shawna Gasik
AVP, Investor Relations
MultiPlan
866-909-7427
investor@multiplan.com

Media Relations
Pamela Walker
AVP, Marketing & Communication
MultiPlan
781-895-3118
press@multiplan.com

MultiPlan Corporation

NYSEAM:CTEV
Details
Headquarters: McLean, VA
CEO: Travis Dalton
Employees: 2800
Organization: PUB

Release Versions
$Cashtags
Hashtags

Contacts

Investor Relations
Luke Montgomery, CFA
SVP, Finance & Investor Relations
MultiPlan
866-909-7427
investor@multiplan.com

Shawna Gasik
AVP, Investor Relations
MultiPlan
866-909-7427
investor@multiplan.com

Media Relations
Pamela Walker
AVP, Marketing & Communication
MultiPlan
781-895-3118
press@multiplan.com

Social Media Profiles
More News From MultiPlan Corporation

Claritev Launches PHCS Novera to Give TPAs More Control Over Network Design Amid Rising Healthcare Costs

MCLEAN, Va.--(BUSINESS WIRE)--As healthcare costs accelerate and employers demand more control over network strategy, Claritev Corporation (NYSE: CTEV), a healthcare technology, data and insights company, today announced the launch of PHCS Novera, a primary network solution designed to help deliver flexible, competitive options. With nearly two-thirds of covered workers enrolled in self-funded insurance plans and healthcare costs projected to rise 9.5% in 2026, employers are increasingly pushin...

Claritev Corporation Announces Participation in BofA Securities Global Health Care Conference 2026

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team will meet with investors and host a presentation at the BofA Securities 2026 Global Health Care Conference in Las Vegas. The Company will webcast its presentation scheduled for 5:00 pm PT on Wednesday, May 13, 2026. To listen to the web...

Claritev Corporation Reports First Quarter 2026 Results

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the first quarter ended March 31, 2026. “Claritev kicked off 2026 the same way we closed 2025, outperforming on the top and bottom lines with focused execution in sales, operations and financials. We are operating with confidence — confidence in our t...
Back to Newsroom